MedTrace Logo

DAHANCA 35: Proton Versus Photon Therapy for Head-neck Cancer

NCT04607694 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2020-10-29

No results posted yet for this study

Summary

Patients with squamous cell carcinoma of the pharynx or larynx and an anticipated benefit of proton radiotherapy in reducing the risk of late dysphagia or xerostomia are randomized to proton or photon radiotherapy (2:1)

Conditions

  • Head-and-neck Cancer

Interventions

RADIATION

Proton radiotherapy

Proton radiotherapy

RADIATION

Photon radiotherapy

Photon radiotherapy

Sponsors & Collaborators

  • The Novo Nordic Foundation

    collaborator OTHER

  • Danish Head and Neck Cancer Group

    lead NETWORK

Principal Investigators

  • Jeppe Friborg, MD, PhD · Danish Head-Neck Cancer Group (DAHANCA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-09
Primary Completion
2025-03-31
Completion
2025-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04607694 on ClinicalTrials.gov